| Article ID | Journal | Published Year | Pages | File Type | 
|---|---|---|---|---|
| 8292642 | Biochemical and Biophysical Research Communications | 2018 | 9 Pages | 
Abstract
												Overexpression of miR-196b suppresses SOCS2 in human LSCC resulting in tumor progression and poor prognosis. miR-196b is a potential marker for prognosis assessment and targeting miR-196b may be a novel valuable strategy for the treatment of LSCC.
											Keywords
												
											Related Topics
												
													Life Sciences
													Biochemistry, Genetics and Molecular Biology
													Biochemistry
												
											Authors
												Xudong Zhao, Wei Zhang, Wenyue Ji, 
											